These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37481170)

  • 1. Monotherapy: Key cause of macrolide-resistant Mycobacterium avium complex disease.
    Loewenstein D; van Balveren L; Lemson A; Hanemaaijer N; Hoefsloot W; van Ingen J
    Respir Med; 2023 Oct; 217():107366. PubMed ID: 37481170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.
    Moon SM; Park HY; Kim SY; Jhun BW; Lee H; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6758-6765. PubMed ID: 27572413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.
    Jhun BW; Kim SY; Moon SM; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2018 Nov; 198(10):1322-1330. PubMed ID: 29877739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes.
    Aoki A; Jinno H; Ogawa K; Nakagawa T; Inagaki T; Wajima T; Okamoto Y; Uchiya KI
    Microbiol Spectr; 2023 Feb; 11(1):e0432622. PubMed ID: 36622171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
    Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ
    Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines.
    Ku JH; Henkle E; Carlson KF; Marino M; Brode SK; Marras TK; Winthrop KL
    Clin Infect Dis; 2023 Feb; 76(3):e1408-e1415. PubMed ID: 35607719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis.
    Park Y; Lee EH; Jung I; Park G; Kang YA
    Respir Res; 2019 Dec; 20(1):286. PubMed ID: 31852452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
    Wallace RJ; Brown-Elliott BA; McNulty S; Philley JV; Killingley J; Wilson RW; York DS; Shepherd S; Griffith DE
    Chest; 2014 Aug; 146(2):276-282. PubMed ID: 24457542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
    Ito Y; Miwa S; Shirai M; Kanai M; Fujita K; Ohba H; Iwaizumi E; Oshima T; Kojima S; Suda T; Hayakawa H
    Respir Med; 2020 Aug; 169():106025. PubMed ID: 32442113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional and molecular epidemiology of macrolide resistance among new Mycobacterium avium complex isolates recovered from HIV-infected patients.
    Gardner EM; Burman WJ; DeGroote MA; Hildred G; Pace NR
    Clin Infect Dis; 2005 Oct; 41(7):1041-4. PubMed ID: 16142672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment strategies with alternative treatment options for patients with Mycobacterium avium complex pulmonary disease.
    Ito M; Koga Y; Hachisu Y; Murata K; Sunaga N; Maeno T; Hisada T
    Respir Investig; 2022 Sep; 60(5):613-624. PubMed ID: 35781424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases.
    Morimoto K; Namkoong H; Hasegawa N; Nakagawa T; Morino E; Shiraishi Y; Ogawa K; Izumi K; Takasaki J; Yoshiyama T; Hoshino Y; Matsuda S; Hayashi Y; Sasaki Y; Ishii M; Kurashima A; Nishimura T; Betsuyaku T; Goto H;
    Ann Am Thorac Soc; 2016 Nov; 13(11):1904-1911. PubMed ID: 27513168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease.
    Choi H; Kim SY; Lee H; Jhun BW; Park HY; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Mycobacterium avium Complex (MAC).
    Griffith DE
    Semin Respir Crit Care Med; 2018 Jun; 39(3):351-361. PubMed ID: 30071550
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a rapid detection method for the macrolide resistance gene in
    Inagaki T; Asahi S; Ogawa K; Nakagawa T; Ohkura T; Osada Y; Nikai T; Yamada K; Yagi T; Uchiya K-i
    Microbiol Spectr; 2024 Apr; 12(4):e0233923. PubMed ID: 38363108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
    BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for Mycobacterium avium complex lung disease.
    Pan SW; Shu CC; Feng JY; Su WJ
    J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S67-S75. PubMed ID: 32446754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.
    Komiya K; Kurashima A; Ihi T; Nagai H; Matsumoto N; Mizunoe S; Ishii H; Takahashi O; Ohta K; Kudoh S; Kadota J
    Int J Antimicrob Agents; 2014 Aug; 44(2):131-5. PubMed ID: 24948577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study.
    Hosono Y; Kitada S; Yano Y; Mori M; Miki K; Miki M; Yoshimura K; Kagawa H; Oshitani Y; Yokota S
    J Infect Chemother; 2018 May; 24(5):353-357. PubMed ID: 29361415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start?
    Nguyen MH; Daley CL
    Clin Chest Med; 2023 Dec; 44(4):771-783. PubMed ID: 37890915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.